| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. | Bioorg Med Chem Lett | 1999 | 1.30 |
| 2 | A new class of leukotriene biosynthesis inhibitor: the development of MK-0591. | J Lipid Mediat | 1993 | 0.81 |